The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
University Department of Medicine, Glasgow Royal Infirmary.
A
A
Crilly
H A
HA
Capell
J
J
Watson
R
R
Madhok
D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D001310:Auranofin / Q000627:therapeutic use*; D001681:Biological Assay; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D012460:Sulfasalazine / Q000627:therapeutic use*
D015850:Interleukin-6; D001310:Auranofin; D012460:Sulfasalazine